COVID-19 vaccine could fundamentally change pandemic direction: WHO

GENEVA (Reuters) - A COVID-19 vaccine may be rolled out by March 2021 to the most vulnerable, which along with other advances could fundamentally change the course of the pandemic, a senior World Health Organization (WHO) official said on Monday. Bruce Aylward also told the WHO's annual ministerial assembly that interim results announced from Pfizer Inc's late-stage vaccine trials were 'very positive'.

Reuters November 10, 2020 00:10:19 IST
COVID-19 vaccine could fundamentally change pandemic direction: WHO

COVID-19 vaccine could fundamentally change pandemic direction: WHO" src="https://images.firstpost.com/wp-content/uploads/reuters/11-2020/10/2020-11-09T162323Z_2_LYNXMPEGA81AG_RTROPTP_2_HEALTH-CORONAVIRUS-WHO.jpg" alt="COVID19 vaccine could fundamentally change pandemic direction WHO" width="300" height="225" />

GENEVA (Reuters) - A COVID-19 vaccine may be rolled out by March 2021 to the most vulnerable, which along with other advances could fundamentally change the course of the pandemic, a senior World Health Organization (WHO) official said on Monday.

Bruce Aylward also told the WHO's annual ministerial assembly that interim results announced from Pfizer Inc's late-stage vaccine trials were "very positive".

"There is still much work to be done, this is just interim results...but some very positive results coming today which should hold great promise hopefully for the entire world as we move forward," Aylward told the 194-member state forum.

Pfizer said its experimental COVID-19 vaccine with partner BioNTech was more than 90% effective.

WHO Director-General Tedros Adhanom Ghebreyesus tweeted shortly afterwards: "We welcome the encouraging vaccine news from @pfizer & @BioNTech_Group & salute all scientists & partners around the who are developing new safe, efficacious tools to beat #COVID19.'

Aylward, referring to all three pillars of the ACT (Access to COVID Tools) Accelerator launched in April, said: "In diagnostics we are in a position to massively expand testing globally, in therapeutics we have sufficient tools right now to substantially reduce the risk of dying from this disease and in the area of vaccines - with the news of today especially - we are on the verge of having the readiness in place to roll out doses for high-risk populations in the late first quarter, early 2nd quarter."

However, he warned that an "acute funding gap" of $4.5 billion could slow access to tests, medicines and vaccines in low- and middle-income countries.

(Reporting by Emma Farge and Stephanie Nebehay ; Editing by Michael Shields)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

U.S. data suggest economic recovery may be weakening
Business

U.S. data suggest economic recovery may be weakening

By Howard Schneider WASHINGTON (Reuters) - The explosive surge in U.S. coronavirus cases this fall has left a question hanging: When will the economy take its own turn for the worse

Fed, ECB heads give COVID-19 vaccine cautious welcome
Business

Fed, ECB heads give COVID-19 vaccine cautious welcome

FRANKFURT/WASHINGTON (Reuters) - The heads of the Federal Reserve and the European Central Bank welcomed the encouraging results in trials of a vaccine candidate for the novel coronavirus but stressed that the economic outlook will remain uncertain. Fed chair Jay Powell and ECB President Christine Lagarde said the economy was still in for a tough time even if the development of a potential vaccine by U.S. drugmaker Pfizer and German partner BioNTech SE was reason for some optimism further ahead

India's October fuel demand marks first year-on-year gain in 8 months
Business

India's October fuel demand marks first year-on-year gain in 8 months

By Sumita Layek (Reuters) - India's fuel consumption in October registered its first year-on-year increase since February, as slowing coronavirus cases and increased mobility accelerated an economic recovery, data showed on Thursday.